Overall, our proof-of-concept study shows a promising avenue for hypoxia-targeted drug delivery that can be adapted to several types of cancers. Keywords: carbonic anhydrase IX; tumor hypoxia targeting; paclitaxel; copper free 'click' chemistry; triple negative breast cancer; albumin nanoparticles; ...